Literature DB >> 17429735

Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats.

Christophe Aubé1, Frédéric Moal, Frédéric Oberti, Jérôme Roux, Vincent Croquet, Yves Gallois, Christophe Argaud, Christine Caron, Paul Calès.   

Abstract

The noninvasive evaluation of liver fibrosis is a major clinical goal in liver diseases. Our aim was to identify MRI parameters to quantify liver fibrosis in vivo in an animal model of liver fibrosis with slight inflammation. We evaluated serum hyaluronate, liver hydroxyproline, area of liver fibrosis (image analysis), and 1.5-T MRI in 10 sham rats and 24 bile duct ligated rats with different stages of liver fibrosis. Liver signal intensity (SI)/muscle SI ratio and liver relaxation times (rT) were measured on T1 and T2 weighted sequences at different echo (TE) or recovery (RT) times of MRI. Among the 66 MRI parameters tested, the highest correlation with the area of fibrosis was observed for rT2 (r=0.78, P < 0.01). The area of liver fibrosis was independently predicted by five MRI variables (adjusted R (2)=0.78, with R (2)=0.64 for rT2 and rT1). Diagnostic accuracy for liver fibrosis was 100% using two variables: liver/muscle SI ratio on T2 at 30-ms TE and liver/muscle SI ratio on T1 at 50-ms RT. We conclude that in this animal model, fibrosis could be diagnosed with an accuracy of 100% using two MRI parameters. The quantification of liver fibrosis was very accurate either with only one MRI parameter (r=0.78 for rT2) or with five parameters (r=0.90) in this cholestatic model.

Entities:  

Mesh:

Year:  2007        PMID: 17429735     DOI: 10.1007/s10620-006-9143-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

Review 1.  [Experimental models of portal hypertension].

Authors:  F Oberti; E Vuillemin; J Fort; P Calès
Journal:  Gastroenterol Clin Biol       Date:  2000-10

2.  Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver.

Authors:  J James; K S Bosch; D C Aronson; J M Houtkooper
Journal:  Liver       Date:  1990-02

3.  Single-shot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phased-array multicoil.

Authors:  Y Amano; T Kumazaki; M Ishihara
Journal:  Acta Radiol       Date:  1998-07       Impact factor: 1.990

4.  Magnetization transfer contrast imaging of liver cirrhosis.

Authors:  J H Chen; J W Chai; W C Shen
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

5.  Vitamin K1 improves survival in bile-duct-ligated rats with cirrhosis.

Authors:  P L Beck; S S Lee
Journal:  J Hepatol       Date:  1995-08       Impact factor: 25.083

6.  Nuclear magnetic resonance imaging of experimentally induced liver disease.

Authors:  D D Stark; N M Bass; A A Moss; B R Bacon; J H McKerrow; C E Cann; A Brito; H I Goldberg
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

7.  Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis.

Authors:  C Aubé; F Oberti; N Korali; M A Namour; D Loisel; J Y Tanguy; E Valsesia; C Pilette; M C Rousselet; P Bedossa; H Rifflet; M Y Maïga; D Penneau-Fontbonne; C Caron; P Calès
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

8.  Noninvasive diagnosis of hepatic fibrosis or cirrhosis.

Authors:  F Oberti; E Valsesia; C Pilette; M C Rousselet; P Bedossa; C Aubé; Y Gallois; H Rifflet; M Y Maïga; D Penneau-Fontbonne; P Calès
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

9.  Thioacetamide- and carbon tetrachloride-induced liver cirrhosis.

Authors:  H Dashti; B Jeppsson; I Hägerstrand; B Hultberg; U Srinivas; M Abdulla; S Bengmark
Journal:  Eur Surg Res       Date:  1989       Impact factor: 1.745

10.  Hepatic cirrhosis: magnetic resonance imaging.

Authors:  H I Goldberg; A A Moss; D D Stark; J McKerrow; B Engelstad; A Brito
Journal:  Radiology       Date:  1984-12       Impact factor: 11.105

View more
  11 in total

1.  T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis.

Authors:  David H Hoffman; Abimbola Ayoola; Dominik Nickel; Fei Han; Hersh Chandarana; Krishna Prasad Shanbhogue
Journal:  Abdom Radiol (NY)       Date:  2020-03

2.  Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls.

Authors:  Mi-Jung Lee; Myung-Joon Kim; Choon-Sik Yoon; Seok Joo Han; Young Nyun Park
Journal:  Pediatr Radiol       Date:  2010-10-20

3.  T2 relaxation time is related to liver fibrosis severity.

Authors:  Alexander R Guimaraes; Luiz Siqueira; Ritika Uppal; Jamu Alford; Bryan C Fuchs; Suguru Yamada; Kenneth Tanabe; Raymond T Chung; Gregory Lauwers; Michael L Chew; Giles W Boland; Duhyant V Sahani; Mark Vangel; Peter F Hahn; Peter Caravan
Journal:  Quant Imaging Med Surg       Date:  2016-04

4.  Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.

Authors:  Petcharakorn Hanpanich; Thewarach Laha; Banchob Sripa; Eimorn Mairiang; Piya Sereerak; Songkaid Upontain; Prasarn Tangkawattana; Paul J Brindley; Sirikachorn Tangkawattana
Journal:  Parasitol Int       Date:  2016-04-30       Impact factor: 2.230

5.  In Vivo MRI Assessment of Hepatic and Splenic Disease in a Murine Model of Schistosomiasis [corrected].

Authors:  Brice Masi; Teodora-Adriana Perles-Barbacaru; Caroline Laprie; Helia Dessein; Monique Bernard; Alain Dessein; Angèle Viola
Journal:  PLoS Negl Trop Dis       Date:  2015-09-22

6.  Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.

Authors:  Michael Haimerl; Niklas Verloh; Florian Zeman; Claudia Fellner; René Müller-Wille; Andreas G Schreyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging.

Authors:  Andreas Müller; Katrin Hochrath; Jonas Stroeder; Kanishka Hittatiya; Günther Schneider; Frank Lammert; Arno Buecker; Peter Fries
Journal:  Biomed Res Int       Date:  2017-01-18       Impact factor: 3.411

8.  Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats.

Authors:  Shuai Zhang; Zhecheng Wang; Jie Zhu; Ting Xu; Yan Zhao; Huanyu Zhao; Fan Tang; Zhenlu Li; Junjun Zhou; Dongyan Gao; Xiaofeng Tian; Jihong Yao
Journal:  Front Pharmacol       Date:  2018-01-19       Impact factor: 5.810

9.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03

10.  The effects of bile duct obstruction on liver volume: an experimental study.

Authors:  Bahtiyar Ertor; Serdar Topaloglu; Adnan Calik; Umit Cobanoglu; Ali Ahmetoglu; Huseyin Ak; Erdem Karabulut; Mithat Kerim Arslan
Journal:  ISRN Surg       Date:  2013-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.